Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1618 1641 1644 1675
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17634586 | DIAGNOSTIC TEST FOR IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS | Final Rejection | University of Massachusetts |
| 18690533 | Suppression of Neurodegeneration with Zinc Transporter Protein 7 | Non-Final OA | The Regents of the University of California |
| 18282749 | COMPOSITIONS AND METHODS FOR TARGETING INFLAMMATORY OR ACTIVATED CELLS AND TREATING OR AMELIORATING INFLAMMATORY CONDITIONS AND PAIN | Non-Final OA | The Regents of the University of California |
| 18278998 | THERAPEUTIC COMPOSITIONS AND METHODS | Non-Final OA | Johns Hopkins University |
| 18558527 | METHODS AND COMPOSITIONS FOR TARGETING OF ANTIGENS AND OTHER POLYPEPTIDES TO FIRST RESPONDER DENDRITIC CELLS | Non-Final OA | THE UNIVERSITY OF CHICAGO |
| 17510887 | NOVEL BIOMOLECULE CONJUGATES AND USES THEREFOR | Final Rejection | Sanford Burnham Prebys Medical Discovery Institute |
| 18683650 | NON-IMMUNOGENIC, HIGH DENSITY POEGMA CONJUGATES | Non-Final OA | Duke University |
| 18255503 | PREVENTION AND TREATMENT OF GRAFT-VERSUS-HOST DISEASE (GVHD) | Final Rejection | CITY OF HOPE |
| 18270472 | FORMULATIONS OF ANTI-CD73 ANTIBODIES | Non-Final OA | I-MAB BIOPHARMA US LIMITED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy